Cerebrovascular support for cognitive processing in hypertensive patients is altered by blood pressure treatment

Hypertension

Volumn 52, Issue 1, 2008, Pages 65-71

  Jennings, J Richard ^a,d   Muldoon, Matthew F ^b   Price, Julie ^b   Christie, Israel C ^b   Meltzer, Carolyn C ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

blocker; Angiotensin converting enzyme inhibitor; Cerebral blood flow; Hypertension; MRI; Positron emission tomography

Indexed keywords

ACETAZOLAMIDE; ATENOLOL; HYDROCHLOROTHIAZIDE; LISINOPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERY DILATATION; ARTICLE; BLOOD FLOWMETRY; BLOOD PRESSURE; BRACHIAL ARTERY; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN REGION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; HUMAN; HYPEREMIA; HYPERTENSION; MALE; MEMORY; MENTAL FUNCTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; VASODILATATION; ANALYSIS OF VARIANCE; BRAIN; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; DRUG EFFECT; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULARIZATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATENOLOL; BLOOD PRESSURE; BRACHIAL ARTERY; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION; COGNITION DISORDERS; FEMALE; HEART RATE; HUMANS; HYPERTENSION; LISINOPRIL; MALE; MEMORY; MIDDLE AGED; VASODILATION;

EID: 46449130992     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.110262     Document Type: Article

References (55)

1. Elias MF, Sullivan LM, Elias PK, D'Agostino RB Sr, Wolf PA, Seshadri S, Au R, Benjamin EJ, Vasan RS. Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring. Hypertension. 2007;49:439 -445.
2. Manolio TA, Olson J, Longstreth WT. Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep. 2003;5:255-261.
3. Muldoon MF, Waldstein SR, Jennings JR. Neuropsychological consequences of antihypertensive medication use. Exp Aging Res. 1995;21: 353-368.
4. Waldstein SR, Manuck SB, Ryan CM, Muldoon MF. Neuropsychological correlates of hypertension: review and methodologic considerations. Psychol Bull. 1991;110:451-468.
5. Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke. 2007;38:1766-1773.
6. Gianaros PJ, Greer PJ, Ryan CM, Jennings JR. Higher blood pressure predicts lower regional grey matter volume: consequences on short-term information processing. Neuroimage. 2006;31:754-765.
7. Jennings JR, Muldoon MF, Ryan C, Price JC, Greer P, Sutton-Tyrrell K, van der Veen FM, Meltzer CC. Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neurology. 2005;64:1358-1365.
8. Raz N, Rodrigue KM, Acker JD. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav Neurosci. 2003;117:1169-1180.
9. Raichle ME. Functional brain imaging. In: Edvinsson L, Krause DN, eds. Cerebral Blood Flow and Metabolism. 2nd ed. Philadelphia, PA: Lip-pincott Williams & Wilkins; 2002:413-419.
10. Raz N. The aging brain observed in vivo: differential changes and their modifiers. In: Cabez R, Nyberg L, Park D, eds. Cognitive Neuroscience of Aging. Oxford, United Kingdom: Oxford University Press; 2005:19-57.
11. Girouard H, Park L, Anrather J, Zhou P, Iadecola C. Angiotensin II attenuates endothelium-dependent responses in the cerebral microcircu-lation through nox-2-derived radicals. Arterioscler Thromb Vasc Biol. 2006;26:826-832.
12. Barenbrock M, Spieker C, Hoeks AP, Zidek W, Rahn KH. Effect of lisinopril and metoprolol on arterial distensibility. Hypertension. 1994; 23:I161-163.
13. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 2000;101: 1653-1659.
14. Dupuis F, Atkinson J, Liminana P, Chillon J-M. Comparative effects of the angiotensin II receptor blocker, telmisartan, and the angiotensin-converting enzyme inhibitor, ramipril, on cerebrovascular structure in spontaneously hypertensive rats. J Hypertens. 2005;23:1061-1066.
15. Bertrand ME. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Curr Med Res Opin. 2004;20:1559-1569.
16. Erzen B, Gradisek P, Poredos P, Sabovic M. Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries. Angiology. 2006;57:187-192.
17. Fu C-H, Yang CCH, Kuo TBJ. Effects of different classes of antihyper-tensive drugs on cerebral hemodynamics in elderly hypertensive patients. Am J Hypertens. 2005;18:1621-1625.
18. Chillon JM, Baumbach GL. Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arterioles in rats. Hypertension. 1999;33:856-861.
19. Heinke W, Zysset S, Hund-Georgiadis M, Olthoff D, von Cramon DY. The effect of esmolol on cerebral blood flow, cerebral vasoreactivity, and cognitive performance: a functional magnetic resonance imaging study. Anesthesiology. 2005;102:41-50.
20. Tan J, Wang JM, Leenen FHH. Inhibition of brain angiotensin-converting enzyme by peripheral administration of trandolapril versus lisinopril in Wistar rats. Am J Hypertens. 2005;18:158-164.
21. Bruhn H, Kleinschmidt A, Boecker H, Merboldt KD, Hanicke W, Frahm J. The effect of acetazolamide on regional cerebral blood oxygenation at rest and under stimulation as assessed by MRI. J Cereb Blood Flow Metab. 1994;14:742-748.
22. Bickler PE, Litt L, Banville DL, Severinghaus JW. Effects of acetazol-amide on cerebral acid-base balance. J Appl Physiol. 1988;65:422-427.
23. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986;314:1657-1664.
24. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R, International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257-265.
25. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, Deanfield JE. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproduc-ibility. Br Heart J. 1995;74:247-253.
26. Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998;78:53-97.
27. Longstreth WT Jr, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke. 1996;27:1274-1282.
28. Boles Ponto LL, Schultz SK, Leonard Watkins G, Hichwa RD. Technical issues in the determination of cerebrovascular reserve in elderly subjects using 15O-water PET imaging. Neuroimage. 2004;21:201-210.
29. Molina C, Sabin JA, Montaner J, Rovira A, Abilleira S, Codina A. Impaired cerebrovascular reactivity as a risk marker for first-ever lacunar infarction: a case-control study. Stroke. 1999;30:2296-2301.
30. Wang Q, Paulson OB, Lassen NA. Effect of nitric oxide blockade by NG-nitro-L-arginine on cerebral blood flow response to changes in carbon dioxide tension. J Cereb Blood Flow Metab. 1992;12:947-953.
31. Wang Q, Paulson OB, Lassen NA. Indomethacin abolishes cerebral blood flow increase in response to acetazolamide-induced extracellular acidosis: a mechanism for its effect on hypercapnia? J Cereb Blood Flow Metab. 1993;13:724-727.
32. 15O] water PET studies in baboons: pre- and post-amphetamine. J Nucl Med. 2002;43: 1090-1100.
33. Iida H, Higano S, Tomura N, Shishido F, Kanno I, Miura S, Murakami M, Takahashi K, Sasaki H, Uemura K. Evaluation of regional differences of tracer appearance time in cerebral tissues using [15O] water and dynamic positron emission tomography. J Cereb Blood Flow Metab. 1988;8:285-288.
34. Buus NH, Jorgensen CG, Mulvany MJ, Sorensen KE. Large and small artery endothelial function in patients with essential hypertension-effect of ACE inhibition and beta-blockade. Blood Press. 2007;16:106-113.
35. Jennings JR, van der Veen FM, Meltzer CC. Verbal and spatial working memory in older individuals: A positron emission tomography study. Brain Res. 2006;1092:177-189.
36. Wager TD, Smith EE. Neuroimaging studies of working memory: a meta-analysis. Cogn Affect Behav Neurosci. 2003;3:255-274.
37. Mentis MJ, Salerno J, Horwitz B, Grady C, Schapiro MB, Murphy DGM, Rapoport SI. Reduction of functional neural connectivity in long-term treated hypertension. Stroke. 1994;25:601-607.
38. Nishimura Y, Onoe H, Morichika Y, Perfiliev S, Tsukada H, Isa T. Time-dependent central compensatory mechanisms of finger dexterity after spinal cord injury. Science. 2007;318:1150-1155.
39. Heiss WD, Kessler J, Thiel A, Ghaemi M, Karbe H. Differential capacity of left and right hemispheric areas for compensation of poststroke aphasia. Ann Neurol. 1999;45:430-438.
40. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu G-Q, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron. 2007;55:697-711.
41. Chillon JM, Baumbach, GL. Autoregulation: arterial and intracranial pressure. In: Edvinsson L, Krause DN, eds. Cerebral Blood Flow and Metabolism. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2002:395-412.
42. Lipsitz LA, Gagnon M, Vyas M, Iloputaife I, Kiely DK, Sorond F, Serrador J, Cheng DM, Babikian V, Cupples LA. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005;45:216-221.
43. Serrador JM, Sorond FA, Vyas M, Gagnon M, Iloputaife ID, Lipsitz LA. Cerebral pressure-flow relations in hypertensive elderly humans: transfer gain in different frequency domains. J Appl Physiol. 2005;98:151-159.
44. Moore MA, Schiffrin EL. Small artery remodeling in hypertension: can it be corrected? Am J Med Sci. 2001;322:7-11.
45. Yang ST, Faraci FM, Heistad DD. Effects of cilazapril on cerebral vasodilatation in hypertensive rats. Hypertension. 1993;22:150-155.
46. Chillon JM, Baumbach GL. Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arteriolar dilatation in hypertensive rats. Hypertension. 2001;37:1388-1393.
47. Hajdu MA, Baumbach GL. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol. 1994;266:H1027-H1033.
48. Iadecola C, Gorelick PB. Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke. 2004;35:348-350.
49. Oku N, Kitagawa K, Imaizumi M, Takasawa M, Piao R, Kimura Y, Kajimoto K, Matsumoto M, Hori M, Hatazawa J. Hemodynamic influences of losartan on the brain in hypertensive patients. Hypertens Res. 2005;28:43-49.
50. Kawakami N, Yamashita T, Nakano S, Ishihara H, Kitahara T, Nakashima K, Kashiwagi S, Ito H. Effect of angiotensin converting enzyme inhibitor on chronic ischemic patients. Acta Neurol Scand. 1996; 166(suppl):93-95.
51. von zur Muhlen B, Millgard J, Lind L. Divergent effects of different beta-blocking agents on endothelium-dependent vasodilatation in the human forearm. Blood Press. 2000;9:287-292.
52. von zur Muhlen B, Kahan T, Hagg A, Millgard J, Lind L. Treatment with irbesartan or atenolol improves endothelial function in essential hypertension. J Hypertens. 2001;19:1813-1818.
53. Girouard H, Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol. 2006; 100:328-335.
54. Liu H, Rainey C, Lauer KK, Piacentine L, Bloom A, Risinger R, Ward BD, Stein E, Li S-J. Peripheral blood pressure changes induced by dobutamine do not alter BOLD signals in the human brain. Neuroimage. 2006;30:745-752.
55. Wang R, Foniok T, Wamsteeker JI, Qiao M, Tomanek B, Vivanco RA, Tuor UI. Transient blood pressure changes affect the functional magnetic resonance imaging detection of cerebral activation. Neuroimage. 2006;31:1-11.